주식

트레이딩뷰에서 모든 시장 추적

서정진 셀트리온 회장이 선택할 대규모 인수·합병(M&A) " 에이비프로바이오

킹살만2023-04-01목록으로 건너뛰기

<br><span style="font-size:14px"><span style="background:#ffffff"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="word-break:break-all"><span style="line-height:22.4px"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="color:#000000"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-variant-caps:normal"><span style="font-weight:400"><span style="letter-spacing:normal"><span style="orphans:2"><span style="text-transform:none"><span style="white-space:normal"><span style="widows:2"><span style="word-spacing:0px"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><a style="box-sizing:border-box; color:#337ab7; text-decoration:underline; -webkit-tap-highlight-color:transparent; font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif"; outline:-webkit-focus-ring-color auto 5px; outline-offset:-2px" href="http://www.paxnet.co.kr/tbbs/list?tbbsType=L&id="><img class="lazy" alt="차트이미지" style="box-sizing:border-box; border:0px; vertical-align:baseline; margin:0px; padding:0px; font-size:14px; background:transparent; list-style:none; word-break:break-all; font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif"; max-width:100%" src="http://www.paxnet.co.kr/tbbs/files/charts/N00820/20230401/fdef775f-4253-4961-ae71-24ea8a37b1d3.png"></a></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br><span style="font-size:14px"><span style="background:#ffffff"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="word-break:break-all"><span style="line-height:22.4px"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="color:#000000"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-variant-caps:normal"><span style="font-weight:400"><span style="letter-spacing:normal"><span style="orphans:2"><span style="text-transform:none"><span style="white-space:normal"><span style="widows:2"><span style="word-spacing:0px"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="border:0px; font-size:36px; margin:0px; padding:0px"><span style="background:transparent"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="line-height:43.2px">서정진 회장 군침 지폐주 예약 ^^</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br><br style="box-sizing:border-box"><br><span style="font-size:14px"><span style="background:#ffffff"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="word-break:break-all"><span style="line-height:22.4px"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="color:#000000"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-variant-caps:normal"><span style="font-weight:400"><span style="letter-spacing:normal"><span style="orphans:2"><span style="text-transform:none"><span style="white-space:normal"><span style="widows:2"><span style="word-spacing:0px"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="border:0px; font-size:17px; margin:0px; padding:0px"><span style="background:#ffffff"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="font-family:HelveticaNeue-Light, "Apple SD Gothic Neo", "Malgun Gothic", "맑은 고딕", Dotum, 돋움, sans-serif"><span style="line-height:20.4px"><span style="color:#333333"><span style="letter-spacing:-1px"> " 에이비프로 플랫폼 기술은 T세포를 이용해 암세포를 사멸하면서 면역과민 반응을 최소화하는 장점 "</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br style="box-sizing:border-box"><br><br style="box-sizing:border-box"><br><span style="font-size:14px"><span style="background:#ffffff"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="word-break:break-all"><span style="line-height:22.4px"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="color:#000000"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-variant-caps:normal"><span style="font-weight:400"><span style="letter-spacing:normal"><span style="orphans:2"><span style="text-transform:none"><span style="white-space:normal"><span style="widows:2"><span style="word-spacing:0px"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="border:0px; font-size:17px; margin:0px; padding:0px"><span style="background:transparent"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="font-family:"Noto Sans KR", "Apple SD Gothic Neo", "Malgun Gothic", "sans-serif", NotoSerif"><span style="line-height:20.4px"><span style="color:#333333">최근 전격 복귀한 서정진 셀트리온 회장이 지난 29일 기자간담회를 통해 대규모 인수·합병(M&A)을 예고하자 에이비프로가 서 회장의 투자를 받을 수 있는 기대가 나오면서 급등한 것으로 풀이된다.</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br><span style="font-size:14px"><span style="background:#ffffff"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="word-break:break-all"><span style="line-height:22.4px"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="color:#000000"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-variant-caps:normal"><span style="font-weight:400"><span style="letter-spacing:normal"><span style="orphans:2"><span style="text-transform:none"><span style="white-space:normal"><span style="widows:2"><span style="word-spacing:0px"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="border:0px; font-size:17px; margin:0px; padding:0px"><span style="background:transparent"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="font-family:"Noto Sans KR", "Apple SD Gothic Neo", "Malgun Gothic", "sans-serif", NotoSerif"><span style="line-height:20.4px"><span style="color:#333333">에이비프로 코퍼레이션은 셀트리온과 이중항체 신약을 개발하기 위해 협력하고 있다.</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br><br style="box-sizing:border-box"><br style="box-sizing:border-box"><br><span style="font-size:14px"><span style="background:#ffffff"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="word-break:break-all"><span style="line-height:22.4px"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="color:#000000"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-variant-caps:normal"><span style="font-weight:400"><span style="letter-spacing:normal"><span style="orphans:2"><span style="text-transform:none"><span style="white-space:normal"><span style="widows:2"><span style="word-spacing:0px"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="border:0px; font-size:17px; margin:0px; padding:0px"><span style="background:transparent"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="font-family:"Noto Sans KR", "Apple SD Gothic Neo", "Malgun Gothic", "sans-serif", NotoSerif"><span style="line-height:20.4px"><span style="color:#333333"><span style="border:0px; font-size:24px; margin:0px; padding:0px"><span style="background:transparent"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="line-height:28.8px">에이비프로 코퍼레이션은 셀트리온과 이중항체 신약을 개발하기 위해 협력하고 있다.</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br><br style="box-sizing:border-box"><br><span style="font-size:14px"><span style="background:#ffffff"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="word-break:break-all"><span style="line-height:22.4px"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="color:#000000"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-variant-caps:normal"><span style="font-weight:400"><span style="letter-spacing:normal"><span style="orphans:2"><span style="text-transform:none"><span style="white-space:normal"><span style="widows:2"><span style="word-spacing:0px"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="border:0px; font-size:16px; margin:0px; padding:0px; text-align:justify"><span style="background:transparent"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="font-family:맑은고딕, "Malgun Gothic", 돋움, dotum, sans-serif"><span style="line-height:19.2px"><span style="color:#333333"><span style="letter-spacing:-0.4px"> 나스닥 상장사 아이맵과 공동개발 중인 면역항암제 'ABL503'과 'ABL111'이다. T세포를 활성화하는 4-1BB를 표적으로 해 T세포의 항암면역 반응을 촉진하는 이중항체 플랫폼 '그랩바디T'를 활용한 파이프라인이다. ABL503은 PD-L1 및 4-1BB 항체를, ABL111은 클라우딘18.2 및 4-1BB 항체를 겨냥하는 이중항체(두 개의 각각 다른 항체들의 항원을 단백질 형태로 결합시킨 항체) 면역항암제다. 현재 미국에서 임상 1상 중이다.</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br><br style="box-sizing:border-box"><br><br style="box-sizing:border-box"><span style="font-size:14px"><span style="background:#ffffff"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="word-break:break-all"><span style="line-height:22.4px"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="color:#000000"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-variant-caps:normal"><span style="font-weight:400"><span style="letter-spacing:normal"><span style="orphans:2"><span style="text-transform:none"><span style="white-space:normal"><span style="widows:2"><span style="word-spacing:0px"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="border:0px; font-size:17px; margin:0px; padding:0px"><span style="background:transparent"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="font-family:"Noto Sans KR", "Apple SD Gothic Neo", "Malgun Gothic", "sans-serif", NotoSerif"><span style="line-height:20.4px"><span style="color:#333333">서 회장은 “이중항체 분야는 에이비엘바이오 등 유망 기업들이 있지만 에이비프로 플랫폼 기술은 T세포를 이용해 암세포를 사멸하면서 면역과민 반응을 최소화하는 장점을 갖고 있다”며 “효능은 기업마다 비슷하지만 부작용 측면에서 충분히 검증됐느냐가 중요하다. 그런 점에서 차별 포인트가 있어 에이비프로와 공동개발을 하게 됐다”라고 말했다.</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br><br style="box-sizing:border-box"><br><br style="box-sizing:border-box"><br><span style="font-size:14px"><span style="background:#ffffff"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="word-break:break-all"><span style="line-height:22.4px"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="color:#000000"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-variant-caps:normal"><span style="font-weight:400"><span style="letter-spacing:normal"><span style="orphans:2"><span style="text-transform:none"><span style="white-space:normal"><span style="widows:2"><span style="word-spacing:0px"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><font color="#333333"><font face="Noto Sans KR, Apple SD Gothic Neo, Malgun Gothic, sans-serif, NotoSerif"><font style="box-sizing: border-box;"><span style="border:0px; font-size:17px; margin:0px; padding:0px"><span style="background:transparent"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="line-height:20.4px">이상훈 ABL바이오 대표 "추가 기술이전, 글로벌 탑티어만 본다"</span></span></span></span></span></span></span></font></font></font></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br><br style="box-sizing:border-box"><br><span style="font-size:14px"><span style="background:#ffffff"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="word-break:break-all"><span style="line-height:22.4px"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="color:#000000"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-variant-caps:normal"><span style="font-weight:400"><span style="letter-spacing:normal"><span style="orphans:2"><span style="text-transform:none"><span style="white-space:normal"><span style="widows:2"><span style="word-spacing:0px"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><font color="#333333"><font face="Noto Sans KR, Apple SD Gothic Neo, Malgun Gothic, sans-serif, NotoSerif"><font style="box-sizing: border-box;"><span style="border:0px; font-size:17px; margin:0px; padding:0px"><span style="background:transparent"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="line-height:20.4px">첨단 신약으로 파킨슨병에 도전하는 국내 개발사 중 가장 주목받는 곳은 글로벌 개발을 진행 중인 에이비엘바이오다.</span></span></span></span></span></span></span></font></font></font></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br><span style="font-size:14px"><span style="background:#ffffff"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="word-break:break-all"><span style="line-height:22.4px"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="color:#000000"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-variant-caps:normal"><span style="font-weight:400"><span style="letter-spacing:normal"><span style="orphans:2"><span style="text-transform:none"><span style="white-space:normal"><span style="widows:2"><span style="word-spacing:0px"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><font color="#333333"><font face="Noto Sans KR, Apple SD Gothic Neo, Malgun Gothic, sans-serif, NotoSerif"><font style="box-sizing: border-box;"><span style="border:0px; font-size:17px; margin:0px; padding:0px"><span style="background:transparent"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="line-height:20.4px">‘ABL바이오 글로벌 1상’·‘메디헬프라인 국내 3상’ 등 주목</span></span></span></span></span></span></span></font></font></font></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br><br style="box-sizing:border-box"><br><br style="box-sizing:border-box"><br><span style="font-size:14px"><span style="background:#ffffff"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="word-break:break-all"><span style="line-height:22.4px"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="color:#000000"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-variant-caps:normal"><span style="font-weight:400"><span style="letter-spacing:normal"><span style="orphans:2"><span style="text-transform:none"><span style="white-space:normal"><span style="widows:2"><span style="word-spacing:0px"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><font color="#333333"><font face="Noto Sans KR, Apple SD Gothic Neo, Malgun Gothic, sans-serif, NotoSerif"><font style="box-sizing: border-box;"><span style="border:0px; font-size:17px; margin:0px; padding:0px"><span style="background:transparent"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="line-height:20.4px">이중항체 면역항암제 ABL503·111 기대</span></span></span></span></span></span></span></font></font></font></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br><span style="font-size:14px"><span style="background:#ffffff"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="word-break:break-all"><span style="line-height:22.4px"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="color:#000000"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-variant-caps:normal"><span style="font-weight:400"><span style="letter-spacing:normal"><span style="orphans:2"><span style="text-transform:none"><span style="white-space:normal"><span style="widows:2"><span style="word-spacing:0px"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><font color="#333333"><font face="Noto Sans KR, Apple SD Gothic Neo, Malgun Gothic, sans-serif, NotoSerif"><font style="box-sizing: border-box;"><span style="border:0px; font-size:17px; margin:0px; padding:0px"><span style="background:transparent"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="line-height:20.4px">사노피 등 기술이전…현금 1500억원 확보</span></span></span></span></span></span></span></font></font></font></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br><span style="font-size:14px"><span style="background:#ffffff"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="word-break:break-all"><span style="line-height:22.4px"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="color:#000000"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-variant-caps:normal"><span style="font-weight:400"><span style="letter-spacing:normal"><span style="orphans:2"><span style="text-transform:none"><span style="white-space:normal"><span style="widows:2"><span style="word-spacing:0px"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><font color="#333333"><font face="Noto Sans KR, Apple SD Gothic Neo, Malgun Gothic, sans-serif, NotoSerif"><font style="box-sizing: border-box;"><span style="border:0px; font-size:17px; margin:0px; padding:0px"><span style="background:transparent"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="line-height:20.4px">국내서 기술이전 선순환 흑자 선구자 꿈꿔</span></span></span></span></span></span></span></font></font></font></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br><span style="font-size:14px"><span style="background:#ffffff"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="word-break:break-all"><span style="line-height:22.4px"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="color:#000000"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-variant-caps:normal"><span style="font-weight:400"><span style="letter-spacing:normal"><span style="orphans:2"><span style="text-transform:none"><span style="white-space:normal"><span style="widows:2"><span style="word-spacing:0px"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><font color="#333333"><font face="Noto Sans KR, Apple SD Gothic Neo, Malgun Gothic, sans-serif, NotoSerif"><font style="box-sizing: border-box;"><span style="border:0px; font-size:17px; margin:0px; padding:0px"><span style="background:transparent"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="line-height:20.4px">이 대표가 올해 유력 기술이전 후보로 꼽은 신약 후보물질은 나스닥 상장사 아이맵과 공동개발 중인 면역항암제 'ABL503'과 'ABL111'이다. </span></span></span></span></span></span></span></font></font></font></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br><span style="font-size:14px"><span style="background:#ffffff"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="word-break:break-all"><span style="line-height:22.4px"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="color:#000000"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-variant-caps:normal"><span style="font-weight:400"><span style="letter-spacing:normal"><span style="orphans:2"><span style="text-transform:none"><span style="white-space:normal"><span style="widows:2"><span style="word-spacing:0px"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><font color="#333333"><font face="Noto Sans KR, Apple SD Gothic Neo, Malgun Gothic, sans-serif, NotoSerif"><font style="box-sizing: border-box;"><span style="border:0px; font-size:17px; margin:0px; padding:0px"><span style="background:transparent"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="line-height:20.4px">이비엘바이오는 당시 해당 계약으로 계약금 7500만달러(약 910억원)를 받았다. </span></span></span></span></span></span></span></font></font></font></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br><br><span style="font-size:14px"><span style="background:#ffffff"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="word-break:break-all"><span style="line-height:22.4px"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="color:#000000"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-variant-caps:normal"><span style="font-weight:400"><span style="letter-spacing:normal"><span style="orphans:2"><span style="text-transform:none"><span style="white-space:normal"><span style="widows:2"><span style="word-spacing:0px"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><font color="#333333"><font face="Noto Sans KR, Apple SD Gothic Neo, Malgun Gothic, sans-serif, NotoSerif"><font style="box-sizing: border-box;"><span style="border:0px; font-size:17px; margin:0px; padding:0px"><span style="background:transparent"><span style="box-sizing:border-box"><span style="vertical-align:baseline"><span style="list-style:none"><span style="font-family:"Nanum Gothic", 굴림, 돋움, "sans-serif""><span style="line-height:20.4px">이후엔 비임상 독성실험 완료(작년), 임상 1상 첫 투여(올해) 등 단기 마일스톤(기술료)으로 약 600억원을 수령했다.</span></span></span></span></span></span></span></font></font></font></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><div style="border:0px; margin:0px; padding:0px; text-align:start; -webkit-text-stroke-width:0px"> </div><br class="Apple-interchange-newline"> 

일베로0민주화

이 글에 나온 종목글에 #종목명 을 달면 여기에 붙습니다

셀트리온068270 · 코스피

이 종목 글 차트 ↗

에이비엘바이오298380 · 코스닥

이 종목 글 차트 ↗

목록링크

신고